Index of reports
> Cases with Atrial Flutter (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Betapace AF (Sotalol) where reactions include atrial flutter. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Betapace AF side effects in 73 year old female
Reported by a consumer/non-health professional from United States on 2012-04-30
Patient: 73 year old female
Reactions: Dyspnoea, Atrial Flutter, Muscular Weakness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Betapace AF
Dosage: 120 mg, bid
Administration route: Oral
Start date: 2012-04-01
Betapace AF
Dosage: 80 mg, bid
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2002-01-01
End date: 2012-04-01
|